|
1
|
Young BC, Levine RJ and Karumanchi SA:
Pathogenesis of preeclampsia. Annu Rev Pathol. 5:173–192. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ji L, Brkić J, Liu M, Fu G, Peng C and
Wang YL: Placental trophoblast cell differentiation: Physiological
regulation and pathological relevance to preeclampsia. Mol Aspects
Med. 34:981–1023. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Escudero C, Celis C, Saez T, Martin San S,
Valenzuela FJ, Aguayo C, Bertoglia P, Roberts JM and Acurio J:
Increased placental angiogenesis in late and early onset
pre-eclampsia is associated with differential activation of
vascular endothelial growth factor receptor 2. Placenta.
35:207–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Armant DR, Fritz R, Kilburn BA, Kim YM,
Nien JK, Maihle NJ, Romero R and Leach RE: Reduced expression of
the epidermal growth factor signaling system in preeclampsia.
Placenta. 36:270–278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kappou D, Sifakis S, Androutsopoulos V,
Konstantinidou A, Spandidos DA and Papantoniou N: Placental mRNA
expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2
is altered in pregnancies complicated by preeclampsia. Placenta.
35:718–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang X, Liu H, Chen X, Chen PH, Fischer
D, Sriraman V, Yu HN, Arkinstall S and He X: Structure of
follicle-stimulating hormone in complex with the entire ectodomain
of its receptor. Proc Natl Acad Sci USA. 109:12491–12496. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bernard DJ, Fortin J, Wang Y and Lamba P:
Mechanisms of FSH synthesis: What we know, what we don't, and why
you should care. Fertil Steril. 93:2465–2485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stilley JA, Christensen DE, Dahlem KB,
Guan R, Santillan DA, England SK, Al-Hendy A, Kirby PA and Segaloff
DL: FSH receptor (FSHR) expression in human extragonadal
reproductive tissues and the developing placenta, and the impact of
its deletion on pregnancy in mice. Biol Reprod. 91:742014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizrachi D and Shemesh M:
Follicle-stimulating hormone receptor and its messenger ribonucleic
acid are present in the bovine cervix and can regulate cervical
prostanoid synthesis. Biol Reprod. 61:776–784. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Celik O, Tagluk ME, Hascalik S, Elter K,
Celik N and Aydin NE: Spectrotemporal changes in electrical
activity of myometrium due to recombinant follicle-stimulating
hormone preparations follitropin alfa and beta. Fertil Steril.
90:(Suppl 4). S1348–S1356. 2008. View Article : Google Scholar
|
|
11
|
Hascalik S, Celik O, Tagluk ME, Yildirim A
and Aydin NE: Effects of highly purified urinary FSH and human
menopausal FSH on uterine myoelectrical dynamics. Mol Hum Reprod.
16:200–206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang
Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, et
al: FSH directly regulates bone mass. Cell. 125:247–260. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu LL, Blair H, Cao J, Yuen T, Latif R,
Guo L, Tourkova IL, Li J, Davies TF, Sun L, et al: Blocking
antibody to the β-subunit of FSH prevents bone loss by inhibiting
bone resorption and stimulating bone synthesis. Proc Natl Acad Sci
USA. 109:14574–14579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu S, Cheng Y, Fan M, Chen D and Bian Z:
FSH aggravates periodontitis-related bone loss in ovariectomized
rats. J Dent Res. 89:366–371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stilley JA, Guan R, Duffy DM and Segaloff
DL: Signaling through FSH receptors on human umbilical vein
endothelial cells promotes angiogenesis. J Clin Endocrinol Metab.
99:E813–E820. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fisher TE, Molskness TA, Villeda A,
Zelinski MB, Stouffer RL and Xu J: Vascular endothelial growth
factor and angiopoietin production by primate follicles during
culture is a function of growth rate, gonadotrophin exposure and
oxygen milieu. Hum Reprod. 28:3263–3270. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Radu A, Pichon C, Camparo P, Antoine M,
Allory Y, Couvelard A, Fromont G, Hai MT and Ghinea N: Expression
of follicle-stimulating hormone receptor in tumor blood vessels. N
Engl J Med. 363:1621–1630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Planeix F, Siraj MA, Bidard FC, Robin B,
Pichon C, Sastre-Garau X, Antoine M and Ghinea N: Endothelial
follicle-stimulating hormone receptor expression in invasive breast
cancer and vascular remodeling at tumor periphery. J Exp Clin
Cancer Res. 34:122015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Faiman C, Ryan RJ, Zwirek SJ and Rubin ME:
Serum FSH and HCG during human pregnancy and puerperium. J Clin
Endocrinol Metab. 28:1323–1329. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Penny R, Olambiwonnu NO and Frasier SD:
Follicle stimulating hormone (FSH) and luteinizing hormone-human
chorionic gonadotropin (LH-HCG) concentrations in paired maternal
and cord sera. Pediatrics. 53:41–47. 1974.PubMed/NCBI
|
|
22
|
Parlow AF, Daane TA and Dignam WJ: On the
concentration of radioimmunoassayable FSH circulating in blood
throughout human pregnancy. J Clin Endocrinol Metab. 31:213–214.
1970. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jaffe RB, Lee PA and Midgley AR Jr: Serum
gonadotropins before, at the inception of, and following human
pregnancy. J Clin Endocrinol Metab. 29:1281–1283. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Winn VD, Haimov-Kochman R, Paquet AC, Yang
YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S,
Pereira L, et al: Gene expression profiling of the human
maternal-fetal interface reveals dramatic changes between
midgestation and term. Endocrinology. 148:1059–1079. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dezso Z, Nikolsky Y, Sviridov E, Shi W,
Serebriyskaya T, Dosymbekov D, Bugrim A, Rakhmatulin E, Brennan RJ,
Guryanov A, et al: A comprehensive functional analysis of tissue
specificity of human gene expression. BMC Biol. 6:492008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eyster KM, Klinkova O, Kennedy V and
Hansen KA: Whole genome deoxyribonucleic acid microarray analysis
of gene expression in ectopic versus eutopic endometriusm. Fertil
Steril. 88:1505–1533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reisinger K, Baal N, McKinnon T, Münstedt
K and Zygmunt M: The gonadotropins: Tissue-specific angiogenic
factors? Mol Cell Endocrinol. 269:65–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fatima LA, Evangelista MC, Silva RS,
Cardoso AP, Baruselli PS and Papa PC: FSH up-regulates angiogenic
factors in luteal cells of buffaloes. Domest Anim Endocrinol.
45:224–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Siraj MA, Pichon C, Radu A and Ghinea N:
Endothelial follicle stimulating hormone receptor in primary kidney
cancer correlates with subsequent response to sunitinib. J Cell Mol
Med. 16:2010–2016. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Siraj A, Desestret V, Antoine M, Fromont
G, Huerre M, Sanson M, Camparo P, Pichon C, Planeix F, Gonin J, et
al: Expression of follicle-stimulating hormone receptor by the
vascular endothelium in tumor metastases. BMC Cancer. 13:2462013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Renner M, Goeppert B, Siraj MA, Radu A,
Penzel R, Wardelmann E, Lehner B, Ulrich A, Stenzinger A, Warth A,
et al: Follicle-stimulating hormone receptor expression in soft
tissue sarcomas. Histopathology. 63:29–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Y, Tong XH, Sun CJ and Zhang WY:
Study of follicle-stimulating hormone receptor and tyrosine
hydroxylase polymorphisms and pre-eclampsia in Chinese Han
population. Zhonghua Yi Xue Za Zhi. 90:1213–1215. 2010.(In
Chinese). PubMed/NCBI
|
|
33
|
Katari S, Wood-Trageser MA, Jiang H,
Kalynchuk E, Muzumdar R, Yatsenko SA and Rajkovic A: Novel
inactivating mutation of the FSH receptor in two siblings of Indian
origin with premature ovarian failure. J Clin Endocrinol Metab.
100:2154–2157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu XQ, Xu SM, Liu JF, Bi XY, Wu YX and Liu
J: Association between FSHR polymorphisms and polycystic ovary
syndrome among Chinese women in north China. J Assist Reprod Genet.
31:371–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Chen Y, Mei S, Liu C, Ma X, Li Y,
Jiang Y, Ha L and Xu X: Single nucleotide polymorphisms in
premature ovarian failure-associated genes in a Chinese Hui
population. Mol Med Rep. 12:2529–2538. 2015.PubMed/NCBI
|
|
36
|
Brownfoot FC, Tong S, Hannan NJ, Hastie R,
Cannon P, Tuohey L and Kaitu'u-Lino TJ: YC-1 reduces placental
sFlt-1 and soluble endoglin production and decreases endothelial
dysfunction: A possible therapeutic for preeclampsia. Mol Cell
Endocrinol. 413:202–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang J, Tao YM, Cheng XY, Zhu TF, Chen ZF,
Yao H and Su LX: Vascular endothelial growth factor affects
dendritic cell activity in hypertensive disorders of pregnancy. Mol
Med Rep. 12:3781–3786. 2015.PubMed/NCBI
|
